Indications for Liver Elastography
Liver elastography is indicated for diagnosing cirrhosis and staging fibrosis in adults with chronic liver disease, particularly chronic hepatitis C, chronic hepatitis B, nonalcoholic fatty liver disease (NAFLD), and chronic alcoholic liver disease. 1
Primary Clinical Indications
Fibrosis Staging and Cirrhosis Detection
Elastography serves as a noninvasive alternative to liver biopsy for assessing liver fibrosis severity across multiple chronic liver conditions 1. The technique is most accurate for detecting advanced fibrosis (≥F2) and cirrhosis, with diagnostic performance improving as fibrosis stage increases 2, 3.
Specific disease contexts include:
- Chronic Hepatitis C and B: VCTE (vibration-controlled transient elastography) demonstrates excellent diagnostic performance for cirrhosis detection 1
- NAFLD with high cirrhosis risk: In patients with advanced age, obesity (particularly central adiposity), diabetes, or elevated ALT >2-3× upper limit of normal (estimated cirrhosis prevalence ~30%), MRE is preferred over VCTE 1
- Chronic alcoholic liver disease: VCTE is validated for fibrosis assessment 1
- Other chronic liver diseases: Including autoimmune hepatitis, primary biliary cirrhosis, and hemochromatosis 1
Portal Hypertension Assessment
Elastography can identify clinically significant portal hypertension and risk-stratify for esophageal varices. Using a liver stiffness cutoff of approximately 17.0 (±2) kPa, VCTE helps triage patients for endoscopic screening 4. This application is particularly valuable in patients with known or suspected compensated cirrhosis.
Treatment Decision-Making and Monitoring
Key applications include:
- Antiviral therapy decisions: Determining need for treatment in chronic hepatitis B and C 5
- Disease progression monitoring: Serial measurements track fibrosis evolution over time 1, 2
- Post-transplant surveillance: Early detection of graft damage after liver transplantation 5
- Preoperative risk assessment: Evaluating liver status before elective surgery to minimize hepatic decompensation risk 4
Technical Considerations and Patient Selection
When NOT to Use Elastography
Elastography measurements are unreliable in:
- Acute hepatitis (active inflammation)
- Recent alcohol consumption
- Food intake within 2-3 hours of examination
- Congestive heart failure
- Extrahepatic cholestasis
- Severe obesity (technical limitations for VCTE) 1
Risk-Stratified Approach for NAFLD
The AGA guideline provides clear risk stratification 1:
High-risk NAFLD patients (referral setting, ~30% cirrhosis prevalence): Use MRE rather than VCTE for cirrhosis detection
Low-risk NAFLD patients (primary care setting, ≤5% cirrhosis prevalence): No recommendation made due to high false-positive rates that may lead to unnecessary downstream testing and patient harm 1
Modality Selection
VCTE is the most commonly used technique—rapid, bedside-capable, widely validated, with acceptable reproducibility 1. It requires minimum 10 valid measurements with interquartile range/median ≤30% 1.
MRE demonstrates superior accuracy in NAFLD and obese patients, with maximum technical failure rate of only 5.8% and excellent reproducibility 1, 6, 7. It is particularly robust when VCTE is technically limited.
Critical Limitations
Elastography does NOT replace liver biopsy when:
- Histologic diagnosis of specific liver disease is needed
- Assessing nonalcoholic steatohepatitis activity
- Evaluating noncirrhotic fibrosis stages in NAFLD (high false-positive rates) 1
- Multiple confounding factors are present
The technique measures liver stiffness as a surrogate for fibrosis but can be influenced by inflammation, cholestasis, and hepatic congestion, requiring careful clinical interpretation within the broader diagnostic context 2.